Grifols SA (GRFS)
8.24
-0.01
(-0.12%)
USD |
NASDAQ |
Apr 02, 16:00
8.245
0.00 (0.00%)
After-Hours: 20:00
Grifols Shareholders Equity (Quarterly) : 6.191B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Akari Therapeutics Plc | 28.33M |
| DBV Technologies SA | 168.77M |
| Cellectis SA | 75.90M |
| Pharma Mar SA | 295.77M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 23.20B |
| Total Liabilities (Quarterly) | 14.26B |
| Debt to Equity Ratio | 1.659 |
| Current Ratio | 2.513 |
| Net Debt Paydown Yield | 2.29% |